Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules.

Saved in:
Bibliographic Details
Title: Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules.
Authors: Ferraris, O.1, Moroso, M.2, Pernet, O.3, Emonet, S.1, Ferrier Rembert, A.1, Paranhos-Baccalà, G.2, Peyrefitte, C.N.1,2
Source: Antiviral Research. Jun2015, Vol. 118, p75-81. 7p.
Database: Environment Complete
Description
ISSN:01663542
DOI:10.1016/j.antiviral.2015.03.005